1Brennan FM,Maini RN,Feldmann M.Role of pro-inflammatory cytokines in rheumatoid arthritis[J].Springer Semin Immunopathol,1998,20(1/2):133-147.
2Miossec P.An update on the cytokine network in rheumatoid arthritis[J].Curr Opin Rheumatol,2004,16(3):218-222.
3Gravallese EM,Goldring SR.Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis[J].Arthritis Rheum,2000,43(10):2143-2151.
4Matsuno H,Yudoh K,Katayama R,et al.The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis(RA):a study using a human RA/SCID mouse chimera[J].Rheumatology(Oxford),2002,41(3):329-337.
5Ohshima S,Mima T,Sasai M,et al.Tumour necrosis factor alpha(TNF-alpha)interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis(RA)synovial cells:a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA[J].Cytokine,2000,12(3):281-288.
6Tak PP,Firestein GS.NF-kappaB:a key role in inflammatory diseases[J].J Clin Invest,2001,107(1):7-11.
7Fujisawa K,Aono H,Hasunuma T,et al.Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha[J].Arthritis Rheum,1996,39(2):197-203.
8Roman-blas JA,Jimenez SA.NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis[J].Osteo Arthritis Cartilage,2006,14(9):839-848.
9Neogi T,Aletaha D,silman AJ,et al.The 2010 American College of rheumatology/European League against Rheumatism classification criteria for rheumatoid arthritis:phase 2 methodological report [ J ] .Arthritis Rheum,2010,62 ( 9 ) :2582-2591.
10Den Broeder AA,Creemers MC,van Gestel AM,et al. Dose titration using the Disease Activity Score ( DAS28 ) in rheumatioid arthritis patients treated with anti-TNF-alpha [J].Rheumatology ( Oxford ),2002,41 ( 6 ) :638-642.
